Clin2
NCT07684248Possibly a fitNot yet recruiting

Butyrate supplement or lifestyle program for fatty liver in type 1 diabetes

Type 1 Diabetes

Part of Hormones & metabolism, Immune system & allergy clinical trials.

This study tests whether a supplement called butyrate or an intensive lifestyle program can help reduce fat in the liver for people with type 1 diabetes. It aims to improve liver health and possibly make blood sugar management easier.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • Be between 18 and 75 years old.
  • Have type 1 diabetes.
  • Have a liver scan (Fibroscan) showing fat in the liver.
  • Be willing to follow the study procedures.
  • Not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07475962Not yet recruiting
Fatty liver in adults with type 1 diabetes

This study looks at how common fatty liver disease is in people with type 1 diabetes and what might increase the risk. By joining, you could help doctors understand and better manage liver health for people with type 1 diabetes.

NCT07750210Not yet recruiting
Liver health study in adults with type 1 diabetes

This study looks at how common a certain type of fatty liver disease (called MASLD) is in adults with Type 1 diabetes. The goal is to learn more about liver health in people with Type 1 diabetes to help improve care.

Sohag, Sohag Governorate
NCT06384313Recruiting
Butyrate supplement for preventing diabetes

This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.

Maastricht, Limburg
NCT07025980Not yet recruiting· Phase 2
Probiotics for fatty liver disease

This study tests whether taking a probiotic supplement (a mix of helpful bacteria) can improve liver health in people with fatty liver disease linked to metabolic syndrome. It may help lower liver enzymes and reduce fat buildup in the liver.

Šibenik, Croatia
NCT06585982Recruiting
Synbiotics for MAFLD: gut health and liver fat study

This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.

Semarang, Semarang
NCT07400367Recruiting
Probiotics and lifestyle changes for fatty liver disease

This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.

New Taipei City

Hear when a new Type 1 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.